Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report
TIZIANA LIFE SCI PLC (TILS.L) Interview – Bloomberg International
Tiziana Life Sci PLC (TILS.L) Publication of Research Note
London, New York, 21 September 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), is pleased to note the publication of a new analyst
Share Talk Weekly Stock Market News, Sunday 20th September 2020
Welcome to the Share Talk Weekly Newsletter as we look back at the week that was.
Tiziana Life Sci PLC (TILS.L) Clinical Study with Nasally Administered Foralumab
Tiziana to Conduct a Clinical Study with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil
Tiziana Life Sci PLC (TILS.L) Demerger of StemPrintER and Distribution in Specie
Demerger of StemPrintER and Distribution in Specie Proposed capital reduction and notice of General Meeting
Tiziana Life Sci PLC (TILS.L) Patent Granted for Anti-IL-6/IL-6
Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for Covid-19 and other pulmonary diseases
Tiziana Life Sci PLC (TILS.L) Patent Granted for Foralumab
Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease
Tiziana Life Sci PLC (TILS.L) Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million
New York and London, August 3, 2020 – Tiziana Life Sciences plc (NASDAQ: TLSA; AIM: TILS) (the “Company” or “Tiziana”), a biotechnology company focused on innovative therapeutics for oncology, inflammation
Share Talk Weekly Stock Market News, 2nd August 2020
On Tuesday 11th August at 6pm Share Talk is proud to presents an Investor Webinar and Q & A with Condor Gold PLC. Condor Gold (CNR), is developing the fully
Tiziana Life Sci PLC (TILS.L) Update on Timings and Corporate Actions – Charting Update
New York/London, 30 July 2020 – Tiziana Life Sciences plc (“Tiziana”, AIM: TILS, NASDAQ: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and
Share Talk Weekly Stock Market News, 19th July 2020
Share Talk highlighted nine, yes nine new company “52-wk high” across our social media platforms, who said private/retail investors do not like the small micro-cap space.
